Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for RISPERIDONE

Ingredient

RISPERIDONE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-RISPERIDONE	0.25MG	TABLET	Resolved	2022-06-16	2022-09-08	162861
TEVA-RISPERIDONE	0.25MG	TABLET	Resolved	2020-06-04	2020-07-09	116672

Previous
1
…
16
17
18

Showing 171 to 172 of 172

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
MYLAN-RISPERIDONE ODT	3MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2021-11-23	2021-11-23	149768
MYLAN-RISPERIDONE ODT	2MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2021-11-23	2021-11-23	149765
MYLAN-RISPERIDONE ODT	1MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2021-11-23	2021-11-23	149762
MYLAN-RISPERIDONE ODT	0.5MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2021-11-23	2021-11-23	149759
PMS-RISPERIDONE ODT	4MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2020-06-17	2020-06-17	118159
PMS-RISPERIDONE ODT	1MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2020-06-17	2020-06-17	118150
PMS-RISPERIDONE ODT	2MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2020-06-17	2020-06-17	118153
PMS-RISPERIDONE ODT	3MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2020-06-17	2020-06-17	118156
TARO-RISPERIDONE	3.0MG	TABLET	Discontinued	2019-08-09	2019-08-10	91284
TARO-RISPERIDONE	2.0MG	TABLET	Discontinued	2020-02-02	2020-02-02	105101

Showing 11 to 20 of 36